Sporanox Generic Name & Formulations
Legal Class
General Description
Pharmacological Class
See Also
How Supplied
Caps—30; Oral soln—150mL
Manufacturer
Generic Availability
YES
Mechanism of Action
Sporanox Indications
Indications
Sporanox Dosage and Administration
Adult
Children
Sporanox Contraindications
Contraindications
Treatment of onychomycosis in CHF, pregnancy, or contemplating pregnancy. Concomitant methadone, disopyramide, dofetilide, dronedarone, quinidine, isavuconazole, ergots, irinotecan, lurasidone, oral midazolam, pimozide, triazolam, felodipine, nisoldipine, ivabradine, ranolazine, eplerenone, cisapride, naloxegol, lomitapide, lovastatin, simvastatin, avanafil, ticagrelor, finerenone, voclosporin. Concomitant colchicine, fesoterodine, or solifenacin in renal/hepatic impairment. Concomitant eliglustat in poor or intermediate CYP2D6 metabolizers or those taking strong or moderate CYP2D6 inhibitors. Concomitant venetoclax in those with CLL/SLL during the dose initiation and ramp-up phase of venetoclax.
Sporanox Boxed Warnings
Boxed Warning
Congestive heart failure and cardiac effects. Drug interactions.
Sporanox Warnings/Precautions
Warnings/Precautions
Sporanox Pharmacokinetics
Absorption
Peak plasma concentrations are reached within 2–5 hours. Absolute oral bioavailability: ~55%.
Distribution
Apparent volume of distribution: >700 L. Plasma protein bound: 99.8%.
Elimination
Sporanox Interactions
Interactions
Sporanox Adverse Reactions
Adverse Reactions
Sporanox Clinical Trials
See Literature
Sporanox Note
Not Applicable
Sporanox Patient Counseling
See Literature